Cambridge Innovation Capital

Cambridge Innovation Capital (CIC) is a Cambridge-based venture investor focused on deep tech and life sciences companies emerging from the Cambridge ecosystem. It was created through a relationship with the University of Cambridge and holds a proprietary agreement giving it access to university research, alongside links with institutes and accelerators.

CIC positions itself mainly as a Series A investor and reports around £0.6bn of assets under management, £0.35bn invested and more than 45 portfolio companies. Holdings include Cambridge GaN Devices, Pragmatic Semiconductor, Riverlane, Salience Labs and Microbiotica. It also runs an entrepreneur-in-residence programme and publishes an annual responsible investment report.